Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Phase 2 clinic trials enrollment for injectable osteoporosis treatment completed
March 16th, 2006
Zelos Therapeutics, Inc. announced that the company has completed enrollment in each of its phase 2 clinical trials for Ostabolin-C. Injectable Ostabolin-C is Zelos' phase 2 candidate for the treatment of osteoporosis. Zelos also has Ostabolin-C gel in phase 2 for the topical treatment of psoriasis. Ostabolin-C is a next-generation PTH analog for the treatment of osteoporosis. Zelos began a multicenter phase 2 clinical trial for Ostabolin-C injection in May 2005 that has enrolled 261 postmenopausal women with low bone mineral density. The trial is a placebo-controlled, double blind, dose finding study. Subjects randomized into the study receive daily injections of one...
Source: Women's Health Weekly (2006-03-16)
|
